ClassID:

112095

C12N2795/14122 - CPC Classification

Classification description:

Bacteriophages; Details ssDNA Bacteriophages; Inoviridae New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20260056202
2026-02-26

USE OF MODIFIED PHAGE FOR CAPTURING AND SUBTYPING OF CANCER CELLS

#2
20260048090
2026-02-19

M13 bacteriophages displaying peptide motifs targeting amyloid-beta, methods and uses thereof

#3
20250222099
2025-07-10

DENDRITIC CELL TARGETING FILAMENTOUS PHAGE-BASED CANCER TREATMENT VACCINE

#4
20230116689
2023-04-13

METHODS AND BIOLOGICAL SYSTEMS FOR DISCOVERING AND OPTIMIZING LASSO PEPTIDES

#5
20230041208
2023-02-09

M13 PHAGE BASED GENE THERAPY PLATFORM

#6
20210205381
2021-07-08

Homogeneous engineered phage populations

#7
20210087538
2021-03-25

Compositions of and methods for in vitro viral genome engineering

#8
20200277605
2020-09-03

Synthetic bacteriophages and bacteriophage compositions

#9
20190343965
2019-11-14

Phage conjugates and uses thereof

#10
20190322988
2019-10-24

Compositions of and methods for in vitro viral genome engineering

#11
20190211312
2019-07-11

Compositions of and methods for in vitro viral genome engineering

#12
20190142882
2019-05-16

Microbial production of pure single stranded nucleic acids

#13
20190024042
2019-01-24

Phage-based matrix for inducing stem cell differentiation and method for preparing the same

#14
20190022155
2019-01-24

Homogeneous engineered phage populations

#15
20180354994
2018-12-13

Fusion proteins comprising P3 of bacteriophage

#16
20180327480
2018-11-15

Phage display vectors and methods of use

#17
20180251534
2018-09-06

POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY

#18
20180155721
2018-06-07

Synthetic bacteriophages and bacteriophage compositions

#19
20170305975
2017-10-26

Fusion proteins comprising P3 of bacteriophage

#20
20170129945
2017-05-11

POLYPEPTIDES COMPRISING A MODIFIED BACTERIOPHAGE G3P AMINO ACID SEQUENCE WITH REDUCED IMMUNOGENICITY

#21
20170115311
2017-04-27

Bacteriophage gene 3 protein compositions and use as amyloid binding agents

#22
20160186147
2016-06-30

Compositions of and methods for in vitro viral genome engineering

#23
20160115223
2016-04-28

Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity

#24
20160103108
2016-04-14

Peptide selectively binding to volatile organic compounds

#25
20160009766
2016-01-14

Bacteriophage gene 3 protein compositions and use as amyloid binding agents

#26
20140335016
2014-11-13

Bacteriophage gene 3 protein compositions and use as amyloid binding agents

#27
20110251106
2011-10-13

pVII phage display

#28
20100322903
2010-12-23

Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof

#29
20100291537
2010-11-18

METHODS AND COMPOSITIONS RELATED TO PHAGE-NANOPARTICLE ASSEMBLIES

#30
20100285136
2010-11-11

System comprising bacteriophages and particles that contain active substances

#31
20100035236
2010-02-11

ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES

#32
20090324554
2009-12-31

METHOD FOR INHIBITING OR TREATING A DISEASE ASSOCIATED WITH INTRACELLULAR FORMATION OF PROTEIN FIBRILLAR OR AGGREGATES

#33
20090137424
2009-05-28

Selective posttranslational modification of phage-displayed polypeptides

#34
20090105090
2009-04-23

Phage Display By Novel Filamentous Bacteriophage

#35
20080241531
2008-10-02

VIRAL FIBERS

#36
20080038717
2008-02-14

ENRICHMENT METHOD FOR VARIANT PROTEINS WITH ALTERED BINDING PROPERTIES

#37
20070178576
2007-08-02

Purification of high-molecular compounds by means of affinity membrane chromatography

#38
20070178448
2007-08-02

Selective posttranslational modification of phage-displayed polypeptides

#39
20060115874
2006-06-01

Enrichment method for variant proteins with altered binding properties

#40
20050180992
2005-08-18

Viral fibers